New understanding and research progression for triple-negative breast cancer
10.3760/cma.j.issn.1673-422X.2013.11.014
- VernacularTitle:三阴性乳腺癌新的认识与研究进展
- Author:
Xinzhao WANG
;
Wenshu ZUO
;
Zhiyong YU
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Drug therapy;
Triple-negative
- From:
Journal of International Oncology
2013;40(11):846-849
- CountryChina
- Language:Chinese
-
Abstract:
Triple-negative breast cancer (TNBC) is a heterogeneous disease.It has distinct risk factors,molecular biology features,clinical presentations and prognosis.TNBC recurrence is common after resection,and the survival rate is low and available treatment options are few after recurrence.To date,chemotherapy is the main treatment strategy for TNBC.There is a great need for new molecular predictive marks and drug targets for improving the efficacy of TNBC treatment.
